Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

计划入组 15 人 · 首次发布于 2014 年 3 月 3 日

Anemia Therapy in Patients With Infective Endocarditis

计划入组 74 人 · 首次发布于 2026 年 4 月 13 日

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients

计划入组 46 人 · 首次发布于 2025 年 3 月 30 日

Anemir

Anemia (Scholar Rock)

aplastic anemia therapeutics

Akebia Therapeutics

United States

Aplastic Anemia And Mds International Foundation Inc

United States

AMELIA HEALTH PTY LTD

Australia

Aqemia and Sanofi Expand AI Drug Discovery Collaboration with New Target Nomination

Genesis Therapeutics Secures $200M Series B to Advance AI-Powered Drug Discovery Platform

Akebia Resubmits FDA Application for Vadadustat in Dialysis-Dependent CKD Anemia